Describing the Epigenetic Mechanisms in Control of Hematopoietic Development and Rapid Inflammatory Responses
描述控制造血发育和快速炎症反应的表观遗传机制
基本信息
- 批准号:10553683
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-31 至 2024-01-30
- 项目状态:已结题
- 来源:
- 关键词:ArginineBacterial InfectionsBase PairingBiological ModelsBiological ProcessBiologyBloodBlood CellsBone MarrowCell Differentiation processCell LineCell LineageCell physiologyCellsChromatinCollaborationsComplexDNA biosynthesisDataDedicationsDefectDevelopmentDiGeorge SyndromeDiseaseEnhancersEpigenetic ProcessExperimental GeneticsFaceFoundationsFutureGene ExpressionGene Expression RegulationGenesGeneticGenetic ModelsGenetic TranscriptionGenomeGoalsHealthHematopoiesisHematopoieticHematopoietic stem cellsHeterochromatinHigh-Throughput Nucleotide SequencingHistone H3Histone H3.3HistonesHumanImmuneImmune responseImmunityIndividualInfectionInflammatory ResponseKnock-outKnowledgeLentivirusLinkListeriaLysineMacrophageMalignant NeoplasmsMapsModelingModificationMusMutationMyeloid CellsOrganismPathway interactionsPatientsPhenotypePhosphorylationPost-Translational Protein ProcessingProcessProteinsReaderRegulationRegulatory PathwayRepressionResearchRoleSerineSignal TransductionSortingSpeedSpleenSystemT-LymphocyteTailTestingTissuesTrainingVariantVertebratesYeastsadult stem cellcell typeepigenetic regulationexhaustionexperimental studyextracellularflyhistone modificationin vivoinducible Creinsightinterestmammalian genomemodel organismmouse modelmutantnovelpathogenprogenitorpromoterresponsescreeningstem cell survivaltherapeutic target
项目摘要
Project Summary
Complex organisms face daunting “epigenetic challenges”. How is a single genome interpreted to instruct over
one thousand distinct cell fates? How do extracellular signals rapidly and robustly turn on select genes in the
three billion base-pair genome? Epigenetic mechanisms underlie balanced blood cell differentiation and the
speed and scope of cellular responses to pathogens or tissue damage—features that define immunity, tolerance,
and survival during infection. Critical to understanding the mechanisms that “solve” these epigenetic challenges
is the study of histones, proteins that package and regulate the genome. The focus of this project is to reveal the
function of histones and histone post-translational modifications (PTMs) in mammalian organisms. Of particular
interest is Histone variant H3.3, which represents 2 of 15 copies of H3 in the genome but is enriched in
dynamically regulated chromatin such as enhancers, promotors and gene bodies. Additionally, H3.3 is the only
H3 that is expressed in a DNA synthesis independent fashion. For these reasons we have focused on studying
the function of H3.3 residues and modifications in hematopoietic development and immune cell function as these
systems reflect complex mammalian development and rapid cellular responses, and are highly relevant to health
and disease.
Preliminary experiments focused on the function of co-transcriptional modification H3.3S31ph, and loss
of this mark abrogates the ability of a macrophage cell line (RAW264.7s) to respond to LPS. To examine which
other H3.3 residues and modifications are required for this rapid transcriptional response, I have developed a
novel knockout and replacement system in BMDMs (Aim 1). Early results have shown that mutation of certain
lysine residues to arginine (H3.3K4R, H3.3K36R) leads to decreased stimulation-induced transcription, whereas
others (H3.3K9R, H3.3K27R) have no effect. To validate the functional relevance of these results, we have
shown the requirement of H3.3 for in vivo immune response to listeria. Our results will inform ongoing studies to
define dedicated mechanisms for rapid transcription.
Additionally, we will use this model of knockout and replacement to determine the function of H3.3 and
key residues in hematopoietic development (Aim 2). Initial experiments shown the requirement for H3.3 in
hematopoietic stem cell survival, and macrophage differentiation. Targeted and unbiased screening of histone
“readers, writers, and erasers” will enable us to link H3.3 mutant phenotypes to chromatin regulatory pathways
and factors. Together these studies will elucidate how epigenetic mechanisms can regulate cellular differentiation
and the speed and scope of cellular responses. By advancing basic knowledge of the epigenetic mechanisms
regulating these cellular processes, the proposed research will have broad implications for basic biology and
disease, as well as direct implications in bacterial infection and patients with H3.3 pathway mutations.
项目摘要
复杂的生物体面临着令人生畏的“表观遗传挑战”。一个单一的基因组是如何解释的,
一千种不同的细胞命运细胞外信号是如何快速而有力地开启细胞内的选择基因的?
30亿个碱基对的基因组表观遗传学机制是平衡血细胞分化和
对病原体或组织损伤的细胞反应的速度和范围-定义免疫、耐受性
感染期间的存活率。理解“解决”这些表观遗传挑战的机制至关重要
是研究组蛋白,即包装和调节基因组的蛋白质。这个项目的重点是揭示
组蛋白和组蛋白翻译后修饰(PTM)在哺乳动物中的功能。特别
感兴趣的是组蛋白变体H3.3,其代表基因组中H3的15个拷贝中的2个,但富含
动态调节的染色质,如增强子、启动子和基因体。此外,H3.3是唯一
H3,其以不依赖DNA合成的方式表达。由于这些原因,我们专注于研究
H3.3残基和修饰在造血发育和免疫细胞功能中的功能,
系统反映了哺乳动物复杂的发育和快速的细胞反应,与健康高度相关。
和疾病
初步实验集中在H3.3S31ph的共转录修饰和功能缺失上
该标记的缺失消除了巨噬细胞系(RAW264.7s)对LPS应答的能力。来测出
其他H3.3残基和修饰是这种快速转录反应所必需的,我已经开发了一种
BMDM中的新型敲除和置换系统(Aim 1)。早期的研究结果表明,
赖氨酸残基与精氨酸(H3.3K4R,H3.3K36R)的结合导致刺激诱导的转录降低,而
其它(H3.3K9R、H3.3K27R)则无影响。为了验证这些结果的功能相关性,我们有
显示了H3.3对于体内免疫应答的需要。我们的结果将为正在进行的研究提供信息,
定义快速转录的专用机制。
此外,我们将使用这种敲除和替换模型来确定H3.3的功能,
造血发育中的关键残基(Aim 2)。最初的实验表明,
造血干细胞存活和巨噬细胞分化。组蛋白的靶向无偏筛选
“阅读器、写入器和擦除器”将使我们能够将H3.3突变表型与染色质调控途径联系起来
和因素。这些研究将共同阐明表观遗传机制如何调节细胞分化
以及细胞反应的速度和范围。通过推进表观遗传机制的基础知识
调节这些细胞过程,拟议的研究将对基础生物学产生广泛的影响,
疾病,以及细菌感染和H3.3途径突变患者的直接影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Daman其他文献
Andrew Daman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Daman', 18)}}的其他基金
Describing the Epigenetic Mechanisms in Control of Hematopoietic Development and Rapid Inflammatory Responses
描述控制造血发育和快速炎症反应的表观遗传机制
- 批准号:
10490961 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
相似海外基金
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
- 批准号:
10574286 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
- 批准号:
10649771 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
- 批准号:
10644889 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
- 批准号:
MR/X031993/1 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
- 批准号:
EP/X014479/1 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
- 批准号:
10588846 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
- 批准号:
10073241 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:
Grant for R&D
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
- 批准号:
10674221 - 财政年份:2023
- 资助金额:
$ 4.77万 - 项目类别:














{{item.name}}会员




